<DOC>
	<DOCNO>NCT01280734</DOCNO>
	<brief_summary>This randomise , double-blind , 3-way crossover , single dose , placebo-controlled study investigate effect night time awaken body sway melatonin zolpidem healthy adult subject age 55 64 year .</brief_summary>
	<brief_title>Investigation Melatonin Zolpidem Effect Postural Instability Healthy Adult Subjects</brief_title>
	<detailed_description />
	<mesh_term>Zolpidem</mesh_term>
	<mesh_term>Melatonin</mesh_term>
	<criteria>1 . The subject must sign informed consent form . 2 . The subject healthy man woman . Women child bear potential within two year menopause must negative urine pregnancy test screening use contraceptive indicate protocol . 3 . The subject 55 64 year age ( extremes include ) . 4 . The subject BMI &gt; 19 kg/m2 &lt; 30 kg/m2 Screening Visit . 5 . The subject normal circadian rhythm , define person usually wake 06:00 09:00 go sleep 21:00 24:00 . 6 . The subject , opinion investigator , generally healthy base assessment medical history examination screen 7 . The subject affiliate , beneficiary social security system . Major 1 . The subject take disallowed medication within 1 week prior first dose IMP ( within 5 halflives prior admission medication ingest , whichever long ) . Disallowed medication prescribe medication overthecounter ( OTC ) medication well herbal medicine know interfere metabolic CYP pathway , St. John 's Wort ( except hormonal contraceptive hormonal substitution therapy ) . Subjects take nonprescribed systemic topical medication may still enter study , opinion investigator , medication interfere study procedure , study result , compromise safety . 2 . The subject weigh &gt; 136 kg . 3 . The subject stand erect unsupported 2 3 minute lose balance stand fix surface eye open . 4 . The subject excessive consumption beverage xanthine base ( 4 cup glass daily ) . 5 . The subject presence history alcohol abuse define alcohol consumption great 21 unit per week men great 14 unit per week woman ; presence history drug abuse within last 6 month , history substance abuse deem relevant investigator . 6 . The subject take investigational product include IMPs ( zolpidem , melatonin ) within 3 month prior admission Day 1 . 7 . The subject take IMPs earlier clinical study . 8 . The subject know hypersensitivity melatonin , zolpidem excipients . 9 . The subject history severe drug allergy hypersensitivity . 10 . The subject pregnant breastfeeding . 11 . The subject presence history sleep disorder , fainting , cardiovascular disease , carotid sinus syndrome , relevant dizziness arrhythmia . 12 . The subject history presence clinically relevant immunological , cardiovascular , pulmonary , metabolic , renal , hepatic , gastrointestinal , endocrinological , haematological , dermatological , venereal , neurological , systemic , ocular psychiatric infectious disease major disorder , sign acute illness . 13 . The subject history cancer , basal cell Stage 1 squamous cell carcinoma skin , remission least 5 year first dose IMP .</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>melatonin</keyword>
	<keyword>circadin</keyword>
	<keyword>zolpidem</keyword>
	<keyword>body sway</keyword>
	<keyword>postural instability</keyword>
</DOC>